XML 101 R68.htm IDEA: XBRL DOCUMENT v3.25.0.1
Goodwill and Intangible Assets (Additional Information) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
May 31, 2023
Aug. 22, 2022
Goodwill [Line Items]          
Goodwill $ 17,905 $ 17,905      
Goodwill, impairment losses 0 0      
Future amortization expense, 2025 26,300        
Future amortization expense, 2026 26,300        
Future amortization expense, 2027 26,300        
Future amortization expense, 2028 26,300        
Future amortization expense, 2029 26,300        
Future amortization expense, thereafter 74,300        
Intangible Assets Abstract          
Amortization expense 25,902 21,784 $ 5,581    
Basilea          
Intangible Assets Abstract          
Upfront fee 4,000        
In-process research and development          
Intangible Assets Abstract          
Amortization expense 0 $ 0      
Acquired Finite-Lived Intangible Asset, Residual Value 2,600        
In-process research and development | XACDURO          
Intangible Assets Abstract          
Intangible assets pertain to product rights and developed technologies       $ 68,700  
La Jolla Pharmaceutical Company          
Goodwill [Line Items]          
Goodwill         $ 6,411
Intangible Assets Abstract          
Intangible assets pertain to product rights and developed technologies 151,000        
Entasis          
Intangible Assets Abstract          
Intangible assets pertain to product rights and developed technologies 106,700        
Entasis | Collaboration agreement          
Intangible Assets Abstract          
Intangible assets pertain to product rights and developed technologies 35,400        
Entasis | In-process research and development          
Intangible Assets Abstract          
Intangible assets pertain to product rights and developed technologies $ 71,300